Recurrence Rate of Hepatocellular Carcinoma After Treatment of Chronic Hepatits C Patients With Direct Acting Antivirals: Randomized Controlled Phase 3 Trial

NCT03551444 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Hepatitis C, Chronic

Interventions

DRUG: Administration of DAA-based treatment

Sponsor

Ain Shams University